Clinical Trial Update: Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides [NA]

View source ↗

Summary

This trial evaluated biodynamic imaging to predict response to gemcitabine in cutaneous T-cell lymphoma (mycosis fungoides); the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Indiana University | Conditions: Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides | NA | Status: TERMINATED